CDK4/6 Inhibitors and Arthralgia: A Single Institution Experience

Background: Aromatase inhibitors (AIs) are associated with musculoskeletal pain in one third (20–47%) of breast cancer patients. Recently, CDK4/6 inhibitors have emerged as a new therapeutic approach in hormone receptor (HR)-positive breast cancer. While hematological and gastrointestinal toxicities...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Med Sci (Basel)
Autori principali: Andrikopoulou, Angeliki, Fiste, Oraianthi, Apostolidou, Kleoniki, Skafida, Efthymia, Markellos, Christos, Liontos, Michalis, Kyriazoglou, Anastasios, Dimopoulos, Meletios-Athanasios, Zagouri, Flora
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2021
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8293403/
https://ncbi.nlm.nih.gov/pubmed/34198899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medsci9020042
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi